NEUTROGENA T/SAL THERAPEUTIC- salicylic acid shampoo 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

NEUTROGENA ® T/Sal ® therapeutic shampoo

Drug Facts

Active ingredient

Salicylic Acid (3%)

Purposes

Anti-dandruff, Anti-seborrheic dermatitis, Anti-psoriasis

Use

Controls the symptoms of dandruff, seborrheic dermatitis and psoriasis.

Warnings

For external use only.

Ask a doctor before use if you have a condition that covers a large area of the body.

When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For best results, use at least twice a week or as directed by a physician .

Other information

Store at room temperature.

Inactive ingredients

Water, Sodium C14-16 Olefin Sulfonate, Cocamidopropyl Betaine, Sodium Chloride, Polyquaternium-22, Sodium Citrate, Hexylene Glycol, Sodium Lauroyl Sarcosinate, , Linoleamidopropyl PG-Dimonium Chloride Phosphate, Sodium Hydroxide, Citric Acid

Questions?

877-256-4247; Outside US, dial collect 215-273-8755 www.neutrogena.com

Distributed by:
JOHNSON & JOHNSON CONSUMER INC.
Skillman, NJ 08558

PRINCIPAL DISPLAY PANEL - 133 mL Bottle Carton

NEUTROGENA ®

T/Sal®

therapeutic

shampoo

Scalp Build-Up

Control

clears and helps

prevent flakes and

scalp build-up

DERMATOLOGIST

RECOMMENDED BRAND

Neutrogena ®

3% SALICYLIC ACID

4.5 FL. OZ. (133 mL)

Ntg001

NEUTROGENA T/SAL THERAPEUTIC 
salicylic acid shampoo
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69968-0434
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID30 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)  
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)  
HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
LINOLEAMIDOPROPYL PROPYLENE GLYCOL-DIMONIUM CHLORIDE PHOSPHATE (UNII: 5Q87K461JO)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69968-0434-41 in 1 CARTON02/06/2020
1133 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:69968-0434-112 in 1 TRAY09/01/2020
229 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H02/06/2020
Labeler - Johnson & Johnson Consumer Inc. (118772437)

Revised: 1/2023
Document Id: ee9ef8ac-e9bc-d3b3-e053-2995a90af2f5
Set id: 54707f0f-6025-4dc3-8be8-7a38bb1363b8
Version: 10
Effective Time: 20230106
 
Johnson & Johnson Consumer Inc.